A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

por Mores, Kendall L., Cummins, Benjamin R., Cassell, Robert J., van Rijn, Richard M.
Publicado 2019

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities

por Meqbil, Yazan J., Su, Hongyu, Cassell, Robert J., Mores, Kendall L., Gutridge, Anna M., Cummins, Benjamin R., Chen, Lan, van Rijn, Richard M.
Publicado 2021

The Meta-Position of Phe(4) in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors

por Cassell, Robert J., Sharma, Krishna K., Su, Hongyu, Cummins, Benjamin R., Cui, Haoyue, Mores, Kendall L., Blaine, Arryn T., Altman, Ryan A., van Rijn, Richard M.
Publicado 2019

G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder

por Gutridge, Anna M., Robins, Meridith T., Cassell, Robert J., Uprety, Rajendra, Mores, Kendall L., Ko, Mee Jung, Pasternak, Gavril W., Majumdar, Susruta, van Rijn, Richard M.
Publicado 2020

Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder

por Gutridge, Anna M., Chakraborty, Soumen, Varga, Balazs R., Rhoda, Elizabeth S., French, Alexander R., Blaine, Arryn T., Royer, Quinten H., Cui, Haoyue, Yuan, Jinling, Cassell, Robert J., Szabó, Márk, Majumdar, Susruta, van Rijn, Richard M.
Publicado 2021